13F HOLDINGS REPORT
Patient Square Capital LP
Quarter ended Q1 2025 · Filed May 14, 2025 · Accession 0000950123-25-005195
Total Value
$241.7M
Positions
19
Other Managers
0
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ROIVANT SCIENCES LTD. | ROIV | 12,480,000 | $125.9M | 52.09% |
| 2 | INSMED INC | INSM | 330,250 | $25.2M | 10.42% |
| 3 | LIQUIDIA CORPORATION | LQDA | 1,522,452 | $22.5M | 9.29% |
| 4 | EYEPOINT PHARMACEUTICALS, INC. | EYPT | 1,481,977 | $8.0M | 3.32% |
| 5 | OCULAR THERAPEUTIX, INC. | OCUL | 920,199 | $6.7M | 2.79% |
| 6 | CULLINAN THERAPEUTICS, INC. | CGEM | 878,897 | $6.7M | 2.75% |
| 7 | NURIX THERAPEUTICS, INC. | NRIX | 447,296 | $5.3M | 2.20% |
| 8 | MIRUM PHARMACEUTICALS, INC. | MIRM | 116,362 | $5.2M | 2.17% |
| 9 | ENLIVEN THERAPEUTICS, INC. | ELVN | 253,838 | $5.0M | 2.07% |
| 10 | SCHOLAR ROCK HOLDING CORPORATION | SRRK | 154,000 | $5.0M | 2.05% |
| 11 | DISC MEDICINE, INC. | IRON | 83,000 | $4.1M | 1.70% |
| 12 | AGIOS PHARMACEUTICALS, INC. | AGIO | 139,732 | $4.1M | 1.69% |
| 13 | KYMERA THERAPEUTICS, INC. | KYMR | 142,201 | $3.9M | 1.61% |
| 14 | PHARVARIS N. V. | PHVS | 245,496 | $3.9M | 1.59% |
| 15 | ALLOGENE THERAPEUTICS, INC. | ALLO | 2,368,186 | $3.5M | 1.43% |
| 16 | BLUEPRINT MEDICINES CORPORATION | 09627Y109 | 38,500 | $3.4M | 1.41% |
| 17 | INTELLIA THERAPEUTICS, INC. | NTLA | 232,781 | $1.7M | 0.68% |
| 18 | SOLENO THERAPEUTICS, INC. | SLNO | 18,600 | $1.3M | 0.55% |
| 19 | VYNE THERAPEUTICS INC. | VYNE | 257,033 | $406,112 | 0.17% |